- Home
- CSBR vs FNGR Comparison
CSBR vs FNGR Comparison
Compare CSBR & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- FNGR
- Stock Information
- Founded
- CSBR 1985
- FNGR 2016
- Country
- CSBR United States
- FNGR Singapore
- Employees
- CSBR N/A
- FNGR N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- FNGR Computer Software: Prepackaged Software
- Sector
- CSBR Health Care
- FNGR Technology
- Exchange
- CSBR Nasdaq
- FNGR Nasdaq
- Market Cap
- CSBR 90.0M
- FNGR 82.3M
- IPO Year
- CSBR 1986
- FNGR N/A
- Fundamental
- Price
- CSBR $6.53
- FNGR $1.36
- Analyst Decision
- CSBR Strong Buy
- FNGR
- Analyst Count
- CSBR 1
- FNGR 0
- Target Price
- CSBR $12.00
- FNGR N/A
- AVG Volume (30 Days)
- CSBR 10.6K
- FNGR 207.1K
- Earning Date
- CSBR 12-12-2025
- FNGR 01-13-2026
- Dividend Yield
- CSBR N/A
- FNGR N/A
- EPS Growth
- CSBR N/A
- FNGR N/A
- EPS
- CSBR 0.21
- FNGR N/A
- Revenue
- CSBR $56,878,000.00
- FNGR $35,881,122.00
- Revenue This Year
- CSBR $7.31
- FNGR N/A
- Revenue Next Year
- CSBR $12.01
- FNGR N/A
- P/E Ratio
- CSBR $30.46
- FNGR N/A
- Revenue Growth
- CSBR 10.11
- FNGR 15.09
- 52 Week Low
- CSBR $4.07
- FNGR $1.03
- 52 Week High
- CSBR $11.99
- FNGR $5.20
- Technical
- Relative Strength Index (RSI)
- CSBR 39.54
- FNGR 44.13
- Support Level
- CSBR $6.67
- FNGR $1.28
- Resistance Level
- CSBR $6.85
- FNGR $1.44
- Average True Range (ATR)
- CSBR 0.17
- FNGR 0.10
- MACD
- CSBR -0.05
- FNGR 0.01
- Stochastic Oscillator
- CSBR 1.79
- FNGR 39.71
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.